Status:
UNKNOWN
Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Collaborating Sponsors:
University of Cambridge
Conditions:
Atrial Fibrillation
Sepsis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To detect atrial fibrillation after infection.
Detailed Description
This study will prospectively recruit patients who are admitted to CUH general medical wards due to an infection or sepsis and develop new/first diagnosed transient AF. In CUH, our previous projects h...
Eligibility Criteria
Inclusion
- Age \>18
- Admission with any infection or sepsis
- Transient AF
- Under general medicine
- Can be anticoagulated or not
- Sinus rhythm at discharge or point of Zio patch placement
Exclusion
- Previous history of AF or paroxysmal AF
- Age less than 18 years
- Pregnancy
- Active and known malignancy
- Recent cardiac or non-cardiac surgery (3 months)
- Recent myocardial infarction (3 months)
- Individuals with skin allergies to plasters and adhesive devices
- Chest wall deformity, skin condition over sticker site
- History of thyroid disease
- Current alcohol intake above recommended limits
- Already has a cardiac monitor or pacemaker inserted
- Known contraindication for anticoagulation therapy
- Patients who lack capacity or have an estimated life expectancy \< 1 year
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT05217485
Start Date
March 1 2022
End Date
March 1 2024
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge University Hospital NHS Foundation Trust
Cambridge, United Kingdom, CB2 0QQ